Multiparametric MRI and T2/FLAIR mismatch complements the World Health Organization 2021 classification for the diagnosis of IDH-mutant 1p/19q non-co-deleted/ATRX-mutant astrocytoma.
dc.contributor.author | Sawlani, V | |
dc.contributor.author | Jen, J P | |
dc.contributor.author | Patel, M | |
dc.contributor.author | Jain, M | |
dc.contributor.author | Haq, H | |
dc.contributor.author | Ughratdar, I | |
dc.contributor.author | Wykes, V | |
dc.contributor.author | Nagaraju, S | |
dc.contributor.author | Watts, C | |
dc.contributor.author | Pohl, U | |
dc.date.accessioned | 2024-01-30T18:33:25Z | |
dc.date.available | 2024-01-30T18:33:25Z | |
dc.date.issued | 2023-12-05 | |
dc.identifier.citation | Sawlani V, Jen JP, Patel M, Jain M, Haq H, Ughratdar I, Wykes V, Nagaraju S, Watts C, Pohl U. Multiparametric MRI and T2/FLAIR mismatch complements the World Health Organization 2021 classification for the diagnosis of IDH-mutant 1p/19q non-co-deleted/ATRX-mutant astrocytoma. Clin Radiol. 2024 Mar;79(3):197-204. doi: 10.1016/j.crad.2023.11.016. Epub 2023 Dec 5. | en_US |
dc.identifier.issn | 0009-9260 | |
dc.identifier.eissn | 1365-229X | |
dc.identifier.doi | 10.1016/j.crad.2023.11.016 | |
dc.identifier.pmid | 38101998 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14200/3484 | |
dc.description.abstract | Aim: To investigate whether T2-weighted imaging-fluid-attenuated inversion recovery (T2/FLAIR) mismatch, T2∗ dynamic susceptibility contrast (DSC) perfusion, and magnetic resonance spectroscopy (MRS) correlated with the histological diagnosis and grading of IDH (isocitrate dehydrogenase)-mutant, 1p/19q non-co-deleted/ATRX (alpha-thalassemia mental retardation X-linked)-mutant astrocytoma. Materials: Imaging of 101 IDH-mutant diffuse glioma cases of histological grades 2-3 (2019-2021) were analysed retrospectively by two neuroradiologists blinded to the molecular diagnosis. T2/FLAIR mismatch sign is used for radio-phenotyping, and pre-biopsy multiparametric MRI images were assessed for grading purposes. Cut-off values pre-determined for radiologically high-grade lesions were relative cerebral blood volume (rCBV) ≥2, choline/creatine ratio (Cho/Cr) ≥1.5 (30 ms echo time [TE]), Cho/Cr ≥1.8 (135 ms TE). Results: Sixteen of the 101 cases showed T2/FLAIR mismatch, all of which were histogenetically confirmed IDH-mutant 1p/19q non-co-deleted/ATRX mutant astrocytomas; 50% were grade 3 (8/16) and 50% grade 2 (8/16). None showed contrast enhancement. Nine of the 16 had adequate multiparametric MRI for analysis. Any positive value by combining rCBV ≥2 with Cho/Cr ≥1.5 (30 ms TE) or Cho/Cr ≥1.8 (135 ms TE) predicted grade 3 histology with sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 100%. Conclusion: The T2/FLAIR mismatch sign detected diffuse astrocytomas with 100% specificity. When combined with high Cho/Cr and raised rCBV, this predicted histological grading with high accuracy. The future direction for imaging should explore a similar integrated layered approach of 2021 classification of central nervous system (CNS) tumours combining radio-phenotyping and grading from structural and multiparametric imaging. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | Copyright © 2023. | |
dc.subject | Clinical pathology | en_US |
dc.title | Multiparametric MRI and T2/FLAIR mismatch complements the World Health Organization 2021 classification for the diagnosis of IDH-mutant 1p/19q non-co-deleted/ATRX-mutant astrocytoma. | en_US |
dc.type | Article | |
dc.source.journaltitle | Clinical Radiology | |
dc.source.country | England | |
rioxxterms.version | NA | en_US |
dc.contributor.trustauthor | Sawlani, Vijay | |
dc.contributor.trustauthor | Jen, Jian Ping | |
dc.contributor.trustauthor | Patel, M | |
dc.contributor.trustauthor | Jain, M | |
dc.contributor.trustauthor | Haq, H | |
dc.contributor.trustauthor | Ughratdar, Ismail | |
dc.contributor.trustauthor | Wykes, Victoria | |
dc.contributor.trustauthor | Nagaraju, Santhosh | |
dc.contributor.trustauthor | Watts, Colin | |
dc.contributor.trustauthor | Pohl, Ute | |
dc.contributor.department | Neurology | en_US |
dc.contributor.department | Neurosurgery | en_US |
dc.contributor.department | Histopathology | en_US |
dc.contributor.department | Pathology | en_US |
dc.contributor.role | Medical and Dental | en_US |
dc.contributor.affiliation | University Hospitals Birmingham NHS FT, Birmingham | en_US |
oa.grant.openaccess | na | en_US |